Forma Therapeutics Holdings, Inc.
FMTXDelisted Oct 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001538927
Forma Therapeutics Holdings, Inc. was delisted on Oct 14, 2022; its insiders filed their last Form 4 on Oct 14, 2022; 139 institutions reported holding it in 13F filings for Q3 2022, worth $835.0M in total; HHLR Advisors (Hillhouse) was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Forma Therapeutics Holdings, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +11 vs. Q1 2022
- Shares held
- 41.7M
- +89.6K (+0.2%) vs. Q1 2022
- Total value
- $287.5M
- −$99.6M (−25.7%) vs. Q1 2022
- New holders
- 22
- 41 more added
- Sold out
- 11
- 26 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FMTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 139 | $835.0M |
| Q2 2022 | 106 | $287.5M |
| Q1 2022 | 98 | $387.7M |
| Q4 2021 | 93 | $587.9M |
| Q3 2021 | 89 | $914.2M |
| Q2 2021 | 83 | $1.00B |
| Q1 2021 | 87 | $1.14B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Forma Therapeutics Holdings, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 2,024,876 | $14.0M | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 3,119,060 | $21.5M | 0.00% | +100,775+3.3% | Added |
| Cormorant Asset Management, LP | 3,172,204 | $21.9M | 1.70% | −896,147−22.0% | Reduced |
| Deep Track Capital, LP | 4,050,000 | $27.9M | 1.93% | +2,390,294+144.0% | Added |
| Armistice Capital, LLC | 4,736,000 | $32.6M | 0.84% | +1,536,000+48.0% | Added |
| Ra Capital Management, L.P. | 9,011,651 | $62.1M | 1.66% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −561,500−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −168,210−100.0% | Sold out |
| Bollard Group LLC | 0 | $0 | 0.00% | −158,200−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −39,252−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −16,845−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −16,795−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,275−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −11,234−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |